Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Valuable Help in Pancreatic Surgery

New software developed at DKFZ to support physicians in surgery planning

No. 44 | 16/08/2005 | by (NM)

More safety for cancer patients during surgery is provided by a new software which enables physicians to plan and perform surgical operations with enhanced precision. Computational molecular biologists of the German Cancer Research Center (Deutsches Krebs¬for¬schungs¬zentrum, DKFZ) have developed a computer program which has now been applied for the first time by surgeons of Heidelberg University Hospitals in the treatment of pancreatic cancer patients. Computational and medical scientists expect that computer-assisted surgery planning will provide physicians with better orientation during surgery and thus enable them to remove tumors more safely for the patient.

The new software has been developed by scientists of the Division of Medical and Biological Informatics headed by Professor Hans-Peter Meinzer in collaboration with DKFZ radiologists. The computer program transforms two-dimensional CT or MRT data into a three-dimensional reconstruction. Thus, it generates an image that can be turned in all directions and illustrates organs and tumors in spatial relationship to neighboring structures.

In cases of pancreatic cancer it is particularly important to have detailed knowledge of the anatomic conditions around the tumor, since various organs and important blood vessels are located in the direct vicinity. Therefore, prior to surgical removal, surgeons need to know exactly whether the tumor is restricted to the pancreas or has already grown into surrounding tissue. The three-dimensional image provides physicians with an exact spatial vision of the tumor’s position and size. Radiologists can use these images to generate more precise diagnostic findings. Surgeons can use this technology preoperatively to obtain precise information about the individual anatomy of their patients. During surgery, the virtual image helps surgeons in orientation.

“The more information one gets about a tumor, the better are the chances of successful surgery,” said Professor Markus W. Büchler, Medical Director of the University Surgical Hospital in Heidelberg. Jointly with his colleagues, PD Dr. Jürgen Weitz and Dr. Hanns-Peter Knaebel of the Department of General, Visceral and Trauma Surgery and Dr. Lars Grenacher and Professor Götz Martin Richter of the Radiology Department, Büchler has now planned and performed pancreatic surgery using the new software for the first time.

Further computer-assisted surgical operations will show whether the new method enables physicians to remove tumor tissue more safely and thoroughly and, thus, to better prevent complications and recurrence following surgery.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS